Medical News

Daily news and information for physicians in a range of specialties and practice settings.

Latest Medical News

Stock Transactions Put Trump HHS Nominee Under Scrutiny
Stock Transactions Put Trump HHS Nominee Under Scrutiny
Democrats charge HHS nominee Tom Price with ethics breaches.
Do Patients Do Better if Their Hospital Room Has a Nice View?
Whether it's of a brick wall, sky, or nature, hospital window view doesn't really matter.
Crying Infants May Calm Down with Acupuncture
Acupuncture might help infantile colic when removing cow's milk doesn't.
EU Approves Suliqua for Type 2 Diabetes Treatment
Suliqua was approved to treat adults with type 2 diabetes.
Non-Adherence to Incident-To Billing Can Prove Costly
Concerning incident-to billing, Carolyn Buppert says, “It’s not something people learn in medical school.” Buppert is a healthcare attorney who specializes in legal and reimbursement issues for nurse practitioners and physicians. She adds, “It’s not something that anyone is necessarily tested for.”
ADHD Candidate Drug Abandoned Following Phase 3 Failure
After spotty trials, Alcobra's MDX met its end as a potential ADHD treatment.
HIV Treatment Could Be to Blame for More Syphilis Cases
Highly active antiretroviral therapy could be hurting immune responses.
Multiple Sclerosis: Cognitive Therapy Eases Anxiety
An MS diagnosis is depressing, but cognitive behavioral therapy helps.
Improved Tests Better at Finding MS in Children
Diagnosing pediatric MS: more accurate with test refinements.

Product News

Investigational Compound Clears Initial Trial to Treat Serious Gut Disorders
Investigational Compound Clears Initial Trial to Treat Serious Gut Disorders
HOST-G904 showed positive results for treating severe bowel conditions.
Long-Acting Opioid Painkiller Gains FDA Approval
The FDA approved a morphine sulfate extended-release tablet (Arymo ER/Egalet) to treat severe pain needing “daily, around-the-clock, long-term opioid treatment".
Ranibizumab Approved by FDA for Myopic Choroidal Neovascularization
The FDA’s decision follows the EU’s decision last month to similarly expand the scope of the drug’s approval to include more specific causes of vision loss and blindness.
FDA Issues Refusal to File for Postoperative Pain Reliever's NDA Bid
Deeming Xaracoll to be a drug/device combination, the Food and Drug Administration notified Innocoll yesterday that it would not be going forward with the New Drug Application they had filed for the product in October.
FDA Rejects Solithromycin for Bacterial Pneumonia
The FDA has issued a complete response letter for the oral and intravenous antibiotic solithromycin as a treatment for patients with community-acquired bacterial pneumonia, due to concerns over hepatotoxicity and manufacturing issues.
FDA Approves Maci to Treat Cartilage Defects in the Knee
The FDA this week announced approval of Maci, “matrix-induced autologous chondrocyte implantation.” The treatment is intended for cartilage defects of the knee, which can eventually lead to osteoarthritis.

Most Popular


$vacMongoViewPlus$ $vAR$